ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-iodinated X-ray Contrast Agents Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-39Y18094
Home | Market Reports | Health| Medical Devices & Equipment
Global Non iodinated X ray Contrast Agents Market Research Report 2024
BUY CHAPTERS

Global Non-iodinated X-ray Contrast Agents Market Research Report 2024

Code: QYRE-Auto-39Y18094
Report
September 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Xi'an Disai Biopharmaceutical Co., Ltd.
Taishan Xinning Pharmaceutical Co., Ltd.
Bracco Diagnostics
Guerbet Group
Shandong Shengli Pharmaceutical Co., Ltd.
Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
Qingdao Hongdie New Materials Co., Ltd.

Non-iodinated X-ray Contrast Agents Market

Non-iodinated X-ray contrast agents are a type of contrast agent that does not contain iodine and is used to help doctors see structures and lesions in the body more clearly in X-ray imaging (such as X-rays, CT scans, etc.). This type of contrast agent is different from common iodine contrast agents and is usually composed of other elements or compounds. It is suitable for patients who are allergic to iodine or for specific diagnostic scenarios.
The global Non-iodinated X-ray Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-iodinated X-ray Contrast Agents include Shandong Shengli Pharmaceutical Co., Ltd., Xi'an Disai Biopharmaceutical Co., Ltd., Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd., Bracco Diagnostics, Guerbet Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-iodinated X-ray Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-iodinated X-ray Contrast Agents.
The Non-iodinated X-ray Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Non-iodinated X-ray Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-iodinated X-ray Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-iodinated X-ray Contrast Agents Market Report

Report Metric Details
Report Name Non-iodinated X-ray Contrast Agents Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shandong Shengli Pharmaceutical Co., Ltd., Xi'an Disai Biopharmaceutical Co., Ltd., Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd., Bracco Diagnostics, Guerbet Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-iodinated X-ray Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-iodinated X-ray Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-iodinated X-ray Contrast Agents Market report?

Ans: The main players in the Non-iodinated X-ray Contrast Agents Market are Shandong Shengli Pharmaceutical Co., Ltd., Xi'an Disai Biopharmaceutical Co., Ltd., Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd., Bracco Diagnostics, Guerbet Group

What are the Application segmentation covered in the Non-iodinated X-ray Contrast Agents Market report?

Ans: The Applications covered in the Non-iodinated X-ray Contrast Agents Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Non-iodinated X-ray Contrast Agents Market report?

Ans: The Types covered in the Non-iodinated X-ray Contrast Agents Market report are Barium Sulfate Type I, Barium Sulfate Type II

Recommended Reports

Contrast Agents Market

Diagnostic Catheters

Radiology & Imaging

1 Non-iodinated X-ray Contrast Agents Market Overview
1.1 Product Definition
1.2 Non-iodinated X-ray Contrast Agents by Type
1.2.1 Global Non-iodinated X-ray Contrast Agents Market Value Comparison by Type (2024-2030)
1.2.2 Barium Sulfate Type I
1.2.3 Barium Sulfate Type II
1.3 Non-iodinated X-ray Contrast Agents by Application
1.3.1 Global Non-iodinated X-ray Contrast Agents Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-iodinated X-ray Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global Non-iodinated X-ray Contrast Agents Revenue 2019-2030
1.4.2 Global Non-iodinated X-ray Contrast Agents Sales 2019-2030
1.4.3 Global Non-iodinated X-ray Contrast Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-iodinated X-ray Contrast Agents Market Competition by Manufacturers
2.1 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-iodinated X-ray Contrast Agents Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Non-iodinated X-ray Contrast Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Product Type & Application
2.7 Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Date of Enter into This Industry
2.8 Global Non-iodinated X-ray Contrast Agents Market Competitive Situation and Trends
2.8.1 Global Non-iodinated X-ray Contrast Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-iodinated X-ray Contrast Agents Players Market Share by Revenue
2.8.3 Global Non-iodinated X-ray Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-iodinated X-ray Contrast Agents Market Scenario by Region
3.1 Global Non-iodinated X-ray Contrast Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-iodinated X-ray Contrast Agents Sales by Region: 2019-2030
3.2.1 Global Non-iodinated X-ray Contrast Agents Sales by Region: 2019-2024
3.2.2 Global Non-iodinated X-ray Contrast Agents Sales by Region: 2025-2030
3.3 Global Non-iodinated X-ray Contrast Agents Revenue by Region: 2019-2030
3.3.1 Global Non-iodinated X-ray Contrast Agents Revenue by Region: 2019-2024
3.3.2 Global Non-iodinated X-ray Contrast Agents Revenue by Region: 2025-2030
3.4 North America Non-iodinated X-ray Contrast Agents Market Facts & Figures by Country
3.4.1 North America Non-iodinated X-ray Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-iodinated X-ray Contrast Agents Sales by Country (2019-2030)
3.4.3 North America Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-iodinated X-ray Contrast Agents Market Facts & Figures by Country
3.5.1 Europe Non-iodinated X-ray Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-iodinated X-ray Contrast Agents Sales by Country (2019-2030)
3.5.3 Europe Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-iodinated X-ray Contrast Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Non-iodinated X-ray Contrast Agents Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-iodinated X-ray Contrast Agents Sales by Region (2019-2030)
3.6.3 Asia Pacific Non-iodinated X-ray Contrast Agents Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-iodinated X-ray Contrast Agents Market Facts & Figures by Country
3.7.1 Latin America Non-iodinated X-ray Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-iodinated X-ray Contrast Agents Sales by Country (2019-2030)
3.7.3 Latin America Non-iodinated X-ray Contrast Agents Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-iodinated X-ray Contrast Agents Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-iodinated X-ray Contrast Agents Sales by Type (2019-2030)
4.1.1 Global Non-iodinated X-ray Contrast Agents Sales by Type (2019-2024)
4.1.2 Global Non-iodinated X-ray Contrast Agents Sales by Type (2025-2030)
4.1.3 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2019-2030)
4.2 Global Non-iodinated X-ray Contrast Agents Revenue by Type (2019-2030)
4.2.1 Global Non-iodinated X-ray Contrast Agents Revenue by Type (2019-2024)
4.2.2 Global Non-iodinated X-ray Contrast Agents Revenue by Type (2025-2030)
4.2.3 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2019-2030)
4.3 Global Non-iodinated X-ray Contrast Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-iodinated X-ray Contrast Agents Sales by Application (2019-2030)
5.1.1 Global Non-iodinated X-ray Contrast Agents Sales by Application (2019-2024)
5.1.2 Global Non-iodinated X-ray Contrast Agents Sales by Application (2025-2030)
5.1.3 Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2019-2030)
5.2 Global Non-iodinated X-ray Contrast Agents Revenue by Application (2019-2030)
5.2.1 Global Non-iodinated X-ray Contrast Agents Revenue by Application (2019-2024)
5.2.2 Global Non-iodinated X-ray Contrast Agents Revenue by Application (2025-2030)
5.2.3 Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2019-2030)
5.3 Global Non-iodinated X-ray Contrast Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shandong Shengli Pharmaceutical Co., Ltd.
6.1.1 Shandong Shengli Pharmaceutical Co., Ltd. Company Information
6.1.2 Shandong Shengli Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.1.5 Shandong Shengli Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Xi'an Disai Biopharmaceutical Co., Ltd.
6.2.1 Xi'an Disai Biopharmaceutical Co., Ltd. Company Information
6.2.2 Xi'an Disai Biopharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.2.5 Xi'an Disai Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
6.3.1 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information
6.3.2 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.3.5 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Qingdao Hongdie New Materials Co., Ltd.
6.4.1 Qingdao Hongdie New Materials Co., Ltd. Company Information
6.4.2 Qingdao Hongdie New Materials Co., Ltd. Description and Business Overview
6.4.3 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.4.5 Qingdao Hongdie New Materials Co., Ltd. Recent Developments/Updates
6.5 Taishan Xinning Pharmaceutical Co., Ltd.
6.5.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
6.5.2 Taishan Xinning Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.5.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Bracco Diagnostics
6.6.1 Bracco Diagnostics Company Information
6.6.2 Bracco Diagnostics Description and Business Overview
6.6.3 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio
6.6.5 Bracco Diagnostics Recent Developments/Updates
6.7 Guerbet Group
6.7.1 Guerbet Group Company Information
6.7.2 Guerbet Group Description and Business Overview
6.7.3 Guerbet Group Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio
6.7.5 Guerbet Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-iodinated X-ray Contrast Agents Industry Chain Analysis
7.2 Non-iodinated X-ray Contrast Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-iodinated X-ray Contrast Agents Production Mode & Process
7.4 Non-iodinated X-ray Contrast Agents Sales and Marketing
7.4.1 Non-iodinated X-ray Contrast Agents Sales Channels
7.4.2 Non-iodinated X-ray Contrast Agents Distributors
7.5 Non-iodinated X-ray Contrast Agents Customers
8 Non-iodinated X-ray Contrast Agents Market Dynamics
8.1 Non-iodinated X-ray Contrast Agents Industry Trends
8.2 Non-iodinated X-ray Contrast Agents Market Drivers
8.3 Non-iodinated X-ray Contrast Agents Market Challenges
8.4 Non-iodinated X-ray Contrast Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Xi'an Disai Biopharmaceutical Co., Ltd.
Taishan Xinning Pharmaceutical Co., Ltd.
Bracco Diagnostics
Guerbet Group
Shandong Shengli Pharmaceutical Co., Ltd.
Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
Qingdao Hongdie New Materials Co., Ltd.
List of Tables
 Table 1. Global Non-iodinated X-ray Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Non-iodinated X-ray Contrast Agents Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Non-iodinated X-ray Contrast Agents Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Non-iodinated X-ray Contrast Agents Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Non-iodinated X-ray Contrast Agents Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Non-iodinated X-ray Contrast Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Non-iodinated X-ray Contrast Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Non-iodinated X-ray Contrast Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-iodinated X-ray Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-iodinated X-ray Contrast Agents as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-iodinated X-ray Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Non-iodinated X-ray Contrast Agents Sales by Region (2019-2024) & (K Units)
 Table 18. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2019-2024)
 Table 19. Global Non-iodinated X-ray Contrast Agents Sales by Region (2025-2030) & (K Units)
 Table 20. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2025-2030)
 Table 21. Global Non-iodinated X-ray Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2019-2024)
 Table 23. Global Non-iodinated X-ray Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2025-2030)
 Table 25. North America Non-iodinated X-ray Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Non-iodinated X-ray Contrast Agents Sales by Country (2019-2024) & (K Units)
 Table 27. North America Non-iodinated X-ray Contrast Agents Sales by Country (2025-2030) & (K Units)
 Table 28. North America Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Non-iodinated X-ray Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Non-iodinated X-ray Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Non-iodinated X-ray Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Non-iodinated X-ray Contrast Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Non-iodinated X-ray Contrast Agents Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Non-iodinated X-ray Contrast Agents Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Non-iodinated X-ray Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Non-iodinated X-ray Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Non-iodinated X-ray Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Non-iodinated X-ray Contrast Agents Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Non-iodinated X-ray Contrast Agents Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Non-iodinated X-ray Contrast Agents Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Non-iodinated X-ray Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Non-iodinated X-ray Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Non-iodinated X-ray Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Non-iodinated X-ray Contrast Agents Sales (K Units) by Type (2019-2024)
 Table 51. Global Non-iodinated X-ray Contrast Agents Sales (K Units) by Type (2025-2030)
 Table 52. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2019-2024)
 Table 53. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Type (2025-2030)
 Table 54. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2019-2024)
 Table 57. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Type (2025-2030)
 Table 58. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Non-iodinated X-ray Contrast Agents Sales (K Units) by Application (2019-2024)
 Table 61. Global Non-iodinated X-ray Contrast Agents Sales (K Units) by Application (2025-2030)
 Table 62. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2019-2024)
 Table 63. Global Non-iodinated X-ray Contrast Agents Sales Market Share by Application (2025-2030)
 Table 64. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Non-iodinated X-ray Contrast Agents Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2019-2024)
 Table 67. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Application (2025-2030)
 Table 68. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Application (2025-2030)
 Table 70. Shandong Shengli Pharmaceutical Co., Ltd. Company Information
 Table 71. Shandong Shengli Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product
 Table 74. Shandong Shengli Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Xi'an Disai Biopharmaceutical Co., Ltd. Company Information
 Table 76. Xi'an Disai Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product
 Table 79. Xi'an Disai Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information
 Table 81. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product
 Table 84. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Qingdao Hongdie New Materials Co., Ltd. Company Information
 Table 86. Qingdao Hongdie New Materials Co., Ltd. Description and Business Overview
 Table 87. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product
 Table 89. Qingdao Hongdie New Materials Co., Ltd. Recent Developments/Updates
 Table 90. Taishan Xinning Pharmaceutical Co., Ltd. Company Information
 Table 91. Taishan Xinning Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product
 Table 94. Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Bracco Diagnostics Company Information
 Table 96. Bracco Diagnostics Description and Business Overview
 Table 97. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product
 Table 99. Bracco Diagnostics Recent Developments/Updates
 Table 100. Guerbet Group Company Information
 Table 101. Guerbet Group Description and Business Overview
 Table 102. Guerbet Group Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Guerbet Group Non-iodinated X-ray Contrast Agents Product
 Table 104. Guerbet Group Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Non-iodinated X-ray Contrast Agents Distributors List
 Table 108. Non-iodinated X-ray Contrast Agents Customers List
 Table 109. Non-iodinated X-ray Contrast Agents Market Trends
 Table 110. Non-iodinated X-ray Contrast Agents Market Drivers
 Table 111. Non-iodinated X-ray Contrast Agents Market Challenges
 Table 112. Non-iodinated X-ray Contrast Agents Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-iodinated X-ray Contrast Agents
 Figure 2. Global Non-iodinated X-ray Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Non-iodinated X-ray Contrast Agents Market Share by Type: 2023 & 2030
 Figure 4. Barium Sulfate Type I Product Picture
 Figure 5. Barium Sulfate Type II Product Picture
 Figure 6. Global Non-iodinated X-ray Contrast Agents Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Non-iodinated X-ray Contrast Agents Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Non-iodinated X-ray Contrast Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Non-iodinated X-ray Contrast Agents Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Non-iodinated X-ray Contrast Agents Sales (2019-2030) & (K Units)
 Figure 14. Global Non-iodinated X-ray Contrast Agents Average Price (US$/Unit) & (2019-2030)
 Figure 15. Non-iodinated X-ray Contrast Agents Report Years Considered
 Figure 16. Non-iodinated X-ray Contrast Agents Sales Share by Manufacturers in 2023
 Figure 17. Global Non-iodinated X-ray Contrast Agents Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Non-iodinated X-ray Contrast Agents Players: Market Share by Revenue in Non-iodinated X-ray Contrast Agents in 2023
 Figure 19. Non-iodinated X-ray Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Non-iodinated X-ray Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 22. North America Non-iodinated X-ray Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 23. United States Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 26. Europe Non-iodinated X-ray Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Non-iodinated X-ray Contrast Agents Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Non-iodinated X-ray Contrast Agents Revenue Market Share by Region (2019-2030)
 Figure 34. China Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Non-iodinated X-ray Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Non-iodinated X-ray Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Non-iodinated X-ray Contrast Agents by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Non-iodinated X-ray Contrast Agents by Type (2019-2030)
 Figure 53. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Non-iodinated X-ray Contrast Agents by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Non-iodinated X-ray Contrast Agents by Application (2019-2030)
 Figure 56. Global Non-iodinated X-ray Contrast Agents Price (US$/Unit) by Application (2019-2030)
 Figure 57. Non-iodinated X-ray Contrast Agents Value Chain
 Figure 58. Non-iodinated X-ray Contrast Agents Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Non ionic Iodine Contrast Media Market Research Report 2024
Global Iodinated X Ray Contrast Media Market Research Report 2024
Global Iodine Contrast Media Market Research Report 2025
Iodinated Contrast Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Industrial Solid Iohexol Market Research Report 2024
Iodine Formulations Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Iodine Contrast Agent Intermediate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Iohexol Injection Market Research Report 2024
Global X Ray Contrast Media Market Research Report 2024
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2030
Global Iodinated Contrast Media in Interventional X Ray Market Research Report 2025
Global Iodinated Contrast Media ICM Market Research Report 2024
Ioxanol Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ultrasound Contrast Agents Market Research Report 2024
Global Iodixanol Injection Market Research Report 2024
Global Medical Contrast Agent Market Insights Forecast to 2030
Global Contrast Agents Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global High Density Contrast Media Market Research Report 2024
Global Contrast Media Market Research Report 2025
Global Non Ionic Contrast Agent Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions